한글목차

수술 로봇 시장 규모는 예측 기간 중 CAGR이 16.5%에 달할 것으로 보이며, 2024년 111억 달러에서 2029년에는 237억 달러에 달할 것으로 예측됩니다.

수술 로봇 시장은 로봇 기술의 발전과 기타 여러 요인에 힘입어 가까운 미래에 급성장할 것으로 예상됩니다. 최소 침습 수술에 대한 수요 증가와 수술센터 및 병원에서의 로봇 시스템 사용 증가가 주요 촉진요인입니다. 이러한 로봇은 향상된 제어, 정확성 및 유연성을 제공하여 다양한 복잡한 치료를 용이하게 하여 합병증 위험과 회복 시간을 줄이고 환자 결과를 개선할 수 있습니다. 또한 의료 부문의 인프라에 대한 지출이 개선되고 모든 수준에서 가격 추세가 개선되고 있는 것도 수술 로봇의 채택을 가속화하고 있습니다. 인구 고령화와 만성질환 증가로 인해 전 세계에서 수술 건수가 증가하고 있습니다. 수술 로봇은 현대 의료 기능에서 점점 더 중요한 위치를 차지하고 있으며, 그 채택이 빠르게 진행되고 있습니다.

오퍼링별로는 기구·액세서리 분야가 수술 로봇 시장에서 최대 시장 점유율을 차지할 것으로 예상됩니다. 기구 및 액세서리는 로봇 보조 수술에 필수적이고 자주 사용되므로 수술 로봇 산업에서 가장 큰 점유율을 차지하고 있습니다. 로봇 팔, 봉합 장비, 로봇 팔, 내시경 전문 기기 등 이러한 맞춤형 전문 기기는 각 수술마다 필요하며, 수술마다 교체 또는 재처리해야 하는 일회용품인 경우가 많습니다. 또한 이러한 기기는 최소 침습 수술부터 기타 치료에 이르기까지 다양한 치료에 대한 수요가 지속적으로 증가하고 있습니다. 이러한 액세서리의 사용 빈도가 높고 반복적인 교체와 정확도를 높이고 환자의 회복 시간을 단축하는 수술기구의 개발로 인해, 이 분야는 선두를 차지하고 있습니다.

용도별로는 일반 수술 분야가 수술 로봇 시장에서 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 일반 수술은 범용성과 폭넓은 적용성을 특징으로 하므로 수술 로봇의 가장 큰 시장을 차지하고 있습니다. 이러한 수술은 특히 비만 수술, 담낭 절제술, 탈장 수술 등 매우 광범위한 스펙트럼을 구성하고 있습니다. 이 모든 수술은 로봇이 제공하는 정확성, 낮은 침습성, 빠른 회복 기간으로 인해 일반적으로 수행되고 있으며, 로봇이 제공하는 정확성 덕분에 큰 혜택을 누리고 있습니다. 만성질환 환자 증가, 최소 침습 수술에 대한 환자의 선호, 로봇 시스템을 도입하는 수술센터와 병원이 증가함에 따라 일반 수술에서 로봇 보조에 대한 수요가 가속화되고 있으며, 그 결과 다른 전문 수술에 비해 로봇 보조의 활용도가 높아지고 있습니다.

최종사용자별로 보면 병원 및 클리닉 부문이 수술 로봇 시장에서 가장 큰 시장 점유율을 차지하고 있습니다. 환자 수가 많고, 수술 범위가 넓으며, 최신 로봇 시스템에 투자할 수 있는 재정적 여력이 있으므로 병원 및 클리닉은 수술 로봇 시장에서 가장 큰 점유율을 차지하고 있습니다. 실제로 정확도를 높이고 회복 시간을 단축하며 환자의 예후를 개선하기 위해 수술 로봇과 같은 혁신적인 툴에 눈을 돌리는 의료 기관은 어떤 분야든 병원 및 클리닉이 가장 먼저 도입하는 경우가 많습니다. 이는 병원이나 진료소 내에서 이러한 정교한 시스템을 운영 및 유지하기 위한 전문 인력과 인프라의 존재에 의해 지원되고 있습니다. 또한 최첨단 치료에 중점을 두고 경쟁력을 유지한다는 것은 바로 로봇 수술에 대한 끊임없는 투자를 통해 변화에 뒤처지지 않는 것을 의미합니다.

세계의 수술 로봇 시장에 대해 조사했으며, 오퍼링별, 용도별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 개요

제4장 주요 인사이트

제5장 시장 개요

• 서론
• 시장 역학
• 업계 동향
• 에코시스템 분석
• 공급망 분석
• 밸류체인 분석
• 기술 분석
• Porter's Five Forces 분석
• 주요 이해관계자와 구입 기준
• 규제 상황
• 특허 분석
• 무역 분석
• 가격 분석
• 상환 분석
• 2024-2025년 주요 컨퍼런스와 이벤트
• 미충족 요구와 최종사용자 기대
• 인접 시장 분석
• 투자와 자금조달 시나리오
• 사례 연구
• 생성형 AI가 수술 로봇 시장에 미치는 영향

제6장 수술 로봇 시장, 오퍼링별

• 서론
• 기구·액세서리
• 로봇 시스템
• 서비스

제7장 수술 로봇 시장, 용도별

• 서론
• 일반 외과
• 부인과 수술
• 정형외과
• 비뇨기과수술
• 뇌신경 외과
• 마이크로서저리
• 이비과 수술
• 기타

제8장 수술 로봇 시장, 최종사용자별

• 서론
• 병원·클리닉
• 외래 수술 센터

제9장 수술 로봇 시장, 지역별

• 서론
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제10장 경쟁 구도

• 개요
• 주요 참여 기업의 전략/비책
• 매출 분석
• 시장 점유율 분석
• 기업 평가 매트릭스 : 주요 참여 기업, 2023년
• 기업 평가 매트릭스 : 스타트업/중소기업, 2023년
• 평가와 재무 지표
• 브랜드/제품 비교
• 경쟁 시나리오

제11장 기업 개요

• 주요 참여 기업
  • INTUITIVE SURGICAL
  • STRYKER
  • MEDTRONIC
  • SMITH+NEPHEW
  • ZIMMER BIOMET
  • ASENSUS SURGICAL INC.
  • SIEMENS HEALTHINEERS AG
  • RENISHAW PLC
  • CMR SURGICAL
  • THINK SURGICAL INC.
  • CORIN GROUP
  • MICROSURE
  • TITAN MEDICAL INC.
  • AVATERAMEDICAL GMBH(A SUBSIDIARY OF AVATERAMEDICAL N.V.)
  • MEDICAL MICROINSTRUMENTS
  • MEDICAROID CORPORATION
  • BRAINLAB AG
  • ECENTIAL ROBOTICS
  • GLOBUS MEDICAL, INC.
  • JOHNSON & JOHNSON
• 기타 기업
  • MOMENTIS INNOVATIVE SURGERY LTD.
  • TINAVI MEDICAL TECHNOLOGIES CO LTD
  • DISTALMOTION
  • MONTERIS
  • NOVUS SAGLIK URUNLERI AR-GE DANISMANLIK

제12장 부록

영문목차

The surgical robots market is projected to reach USD 23.7 billion by 2029 from USD 11.1 billion in 2024, at a CAGR of 16.5% during the forecast period. The surgical robots market will grow rapidly in the near future, boosted by the development of robotic technology and several other factors. Growing need for minimally invasive operations and increasing usage by robotic systems in surgery centers and hospitals are key drivers. These robots make a variety of intricate treatments easier by providing enhanced control, precision, and flexibility, therefore improving patient outcomes with lessened risk of complications and recovery time. Furthermore, with improved spending on health sector infrastructure and positive pricing trends at all levels, it accelerates the adoption of surgical robots. Again, an aging population and the mounting burden of chronic diseases have fired up the volume of surgeries across the globe. The growing volume naturally calls for surgical robots; their adoption becomes rapid as they find their place more and more in the lap of modern medical functioning.

"By offering, instruments and accessories segment is expected to have the largest market share in the surgical robots market."

Based on offering, the instruments and accessories segment is expected to hold the largest market share in the surgical robots market. Because they are essential and used frequently in robotically assisted procedures, instruments and accessories have the largest share of the surgical robotics industry. Such custom specialist instruments, among them robotic arms, suturing devices, robotic arms, and specialist endoscopic tools, for each procedure are required and are frequently single-use items that need to be replaced or reprocessed after each surgery. Besides, these instruments are in constant demand for various treatments, from minimally invasive surgeries to others. Their position at the top comes partly from the high rate of use and repeated replacing of these accessories and partly from the development of surgical instruments that are supposed to help precision and reduce recuperation times for patients.

"By application, general surgery segment is expected to have the largest market share in the surgical robots market."

Based on application, the general surgery segment is expected to hold the largest market share in the surgical robots market. General surgery represents the largest market for surgical robots, as versatility and wide applicability characterize this application. Such procedures do make up an extremely broad spectrum, which includes, among others, bariatric surgeries, cholecystectomies, hernia repairs, and alike. All these procedures are usually carried out and benefit immensely from the accuracy and less invasiveness and faster recovery periods offered by the robots. Rising cases of chronic diseases, patients' inclination towards less invasive procedures, and surgical centers and hospitals adopting robotic systems have accelerated the demand for robotic assistance in general surgeries, resulting in a higher utilization rate as compared to other specialized surgeries.

"By end user, hospitals & clinics segment is expected to have the largest market share in the surgical robots market."

Based on end user, the hospitals & clinics segment accounted for the largest market share of the surgical robots market. With large patient volumes, a wide range of surgical procedures, and strong financial resources that enable them to invest in the latest robotic systems, it is hospitals and clinics that command the largest share in the surgical robotics market. Indeed, these are usually among the first institutions within any medical field that look toward innovative tools such as surgical robots to improve precision, reduce recovery time, and ensure better outcomes for patients. This is further supported by the presence of specialized personnel and infrastructure to run and maintain such sophisticated systems within hospitals and clinics. Moreover, with their focus on cutting-edge treatment, keeping themselves competitive achieves just that: keeping them abreast of change through constant investment in robotic surgery.

"By region, North American region is expected to have the largest market share in the surgical robots market."

At present, North America holds the maximum share of the surgical robots industry for a number of key considerations. Advanced healthcare systems and large investments in medical technology characterize the region. Additionally, rapid adoption of innovative concepts is showcased. Further, growth of this industry is accelerated with the presence of key market players like Stryker and Intuitive Surgical. Quite favorable government regulations in North America, a high frequency of chronic conditions requiring surgical procedures, and strong purchasing power have all combined to give this region top market share in the surgical robots industry. Its leadership position is further maintained as it continues in its commitment to research and development, facilitating further developments.

A breakdown of the primary participants (supply-side) for the surgical robots market referred to for this report is provided below:

• By Company Type: Tier 1-35%, Tier 2-40%, and Tier 3-25%
• By Designation: C-level-20%, Director Level-35%, and Others-45%
• By Region: North America-27%, Europe-25%, Asia Pacific-30%, Latin America- 8%, Middle East & Africa-10% .

Prominent players in the surgical robots market are Intutive Surgical (US), Stryker (US), Medtronic (Ireland), Smith+Nephew (UK), Zimmer Biomet (US), Asensus Surgical (US), Siemens Healthineers (Germany), CMR Surgical (UK), Johnson & Johnson (US), Renishaw Plc (UK), Avateramedical GmbH (Germany), Brainlab AG (Germany), Think Surgical (US), Medicaroid Corporation (Japan), Globus Medical, Inc. (US), Corin Group (UK), Ecential Robotics (France), Titan Medical, Inc. (Canada), TINAVI Medical (China), Monteris (US), Microsure (Netherlands), Medical Microinstruments (US), Momentis Innovative Surgery (Israel), Distalmotion (Switzerland), Novus Arge (Turkey).

Research Coverage:

The report analyzes the surgical robots market and aims at estimating the market size and future growth potential of this market based on various segments such as offering, application, end user and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall prefilled syringes market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (increasing adoption of surgical robots, increasing funding, technological advancements, improving reimbursement), restraints (high cost), opportunities (increasing penetration of surgical robots in ASCs, Growth opportunities in emerging markets), challenges (surgical errors)
• Market Penetration: It includes extensive information on products offered by the major players in the global the surgical robots market. The report includes various segments in offering, application, end user and region.
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global surgical robots market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by offering, application, end user and region.
• Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global the surgical robots market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global surgical robots market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES
• 1.6 CURRENT TRENDS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4 MARKET SHARE ESTIMATION
• 2.5 ASSUMPTIONS
• 2.6 LIMITATIONS
  • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.6.2 SCOPE-RELATED LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 SURGICAL ROBOTS MARKET OVERVIEW
• 4.2 ASIA PACIFIC: SURGICAL ROBOTS MARKET, BY OFFERING AND COUNTRY (2023)
• 4.3 SURGICAL ROBOTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 SURGICAL ROBOTS MARKET, BY REGION (2022-2029)
• 4.5 SURGICAL ROBOTS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Advantages of robot-assisted surgery
    • 5.2.1.2 Technological advancements
    • 5.2.1.3 Improving reimbursement scenario
    • 5.2.1.4 Increasing adoption of surgical robots
    • 5.2.1.5 Increasing funding for medical robot research
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of robotic systems
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Increasing penetration of surgical robots in ASCs
    • 5.2.3.2 Growth opportunities in emerging markets
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Surgical errors
• 5.3 INDUSTRY TRENDS
  • 5.3.1 RISING NUMBER OF MINIMALLY INVASIVE SURGERIES USING SURGICAL ROBOTS
  • 5.3.2 TELEPRESENCE AND REMOTE SURGERY
  • 5.3.3 EMERGENCE OF SURGICAL NAVIGATION AND IMAGING TECHNOLOGIES
  • 5.3.4 REGIONAL OVERVIEW OF ROBOTIC SURGICAL PROCEDURES
  • 5.3.5 REGIONAL OVERVIEW OF COMMONLY USED SURGICAL ROBOTIC SYSTEMS, 2020-2023
  • 5.3.6 REGIONAL OVERVIEW OF PATIENT PREFERENCE FOR SURGICAL ROBOTIC SYSTEMS
• 5.4 ECOSYSTEM ANALYSIS
• 5.5 SUPPLY CHAIN ANALYSIS
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 TECHNOLOGY ANALYSIS
  • 5.7.1 KEY TECHNOLOGIES
    • 5.7.1.1 Robotic arms and instruments
    • 5.7.1.2 Artificial Intelligence (AI) and Machine Learning (ML)
    • 5.7.1.3 Telepresence
    • 5.7.1.4 5G Technology
  • 5.7.2 COMPLEMENTARY TECHNOLOGIES
    • 5.7.2.1 Augmented Reality (AR) and Virtual Reality (VR)
    • 5.7.2.2 3D Printing
• 5.8 PORTER'S FIVE FORCES ANALYSIS
  • 5.8.1 THREAT OF NEW ENTRANTS
  • 5.8.2 THREAT OF SUBSTITUTES
  • 5.8.3 BARGAINING POWER OF SUPPLIERS
  • 5.8.4 BARGAINING POWER OF BUYERS
  • 5.8.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.9 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.9.2 BUYING CRITERIA
• 5.10 REGULATORY LANDSCAPE
  • 5.10.1 NORTH AMERICA
    • 5.10.1.1 US
  • 5.10.2 EUROPE
  • 5.10.3 ASIA PACIFIC
    • 5.10.3.1 Japan
    • 5.10.3.2 China
    • 5.10.3.3 India
  • 5.10.4 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATION
• 5.11 PATENT ANALYSIS
  • 5.11.1 PATENT PUBLICATION TRENDS FOR SURGICAL ROBOTS
• 5.12 TRADE ANALYSIS
  • 5.12.1 IMPORT ANALYSIS FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL & SURGICAL SCIENCES
  • 5.12.2 EXPORT ANALYSIS FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL & SURGICAL SCIENCES
• 5.13 PRICING ANALYSIS
  • 5.13.1 AVERAGE SELLING PRICE, BY KEY PLAYER
  • 5.13.2 AVERAGE SELLING PRICE TREND, BY REGION
• 5.14 REIMBURSEMENT ANALYSIS
• 5.15 KEY CONFERENCES & EVENTS, 2024-2025
• 5.16 UNMET NEEDS AND END-USER EXPECTATIONS
  • 5.16.1 UNMET NEEDS
  • 5.16.2 END-USER EXPECTATIONS IN SURGICAL ROBOTS MARKET
• 5.17 ADJACENT MARKET ANALYSIS
• 5.18 INVESTMENT & FUNDING SCENARIO
• 5.19 CASE STUDIES
  • 5.19.1 REVOLUTIONISING FUTURE OF SURGERY WITH HIGH-PRECISION ROBOTS
  • 5.19.2 HUNJAN HOSPITAL DEPLOYS ORTHOPEDIC SURGICAL ROBOT FOR KNEE REPLACEMENT SURGERY
  • 5.19.3 BIONAUT LABS CREATES REMOTE-CONTROLLED MICRO-ROBOTS TO TARGET BRAIN DISEASES
• 5.20 IMPACT OF GENERATIVE AI ON SURGICAL ROBOTS MARKET

6 SURGICAL ROBOTS MARKET, BY OFFERING

• 6.1 INTRODUCTION
• 6.2 INSTRUMENTS & ACCESSORIES
  • 6.2.1 NEED FOR RECURRENT PURCHASE OF INSTRUMENTS & ACCESSORIES TO DRIVE MARKET GROWTH
• 6.3 ROBOTIC SYSTEMS
  • 6.3.1 LAPAROSCOPIC ROBOTIC SYSTEMS
    • 6.3.1.1 Growing popularity of laparoscopic robotic surgeries to drive market
  • 6.3.2 ORTHOPEDIC ROBOTIC SYSTEMS
    • 6.3.2.1 Rising number of market players offering orthopedic robots to support growth
  • 6.3.3 NEUROSURGICAL ROBOTIC SYSTEMS
    • 6.3.3.1 Reproducibility and precision to drive uptake
  • 6.3.4 OTHER ROBOTIC SYSTEMS
• 6.4 SERVICES
  • 6.4.1 ONGOING NEED FOR SERVICES TO PROPEL MARKET

7 SURGICAL ROBOTS MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 GENERAL SURGERY
  • 7.2.1 GROWING PREFERENCE FOR ROBOT-ASSISTED GENERAL SURGICAL PROCEDURES TO DRIVE MARKET GROWTH
• 7.3 GYNECOLOGICAL SURGERY
  • 7.3.1 RISING NUMBER OF HYSTERECTOMIES TO INCREASE DEMAND FOR SURGICAL ROBOTS
• 7.4 ORTHOPEDIC SURGERY
  • 7.4.1 GROWING PREFERENCE FOR KNEE RECONSTRUCTION PROCEDURES TO SUPPORT GROWTH
• 7.5 UROLOGICAL SURGERY
  • 7.5.1 GROWING PREVALENCE OF UROLOGICAL DISEASES TO FUEL DEMAND FOR SURGICAL ROBOTS
• 7.6 NEUROSURGERY
  • 7.6.1 INCREASING USE OF ROBOTIC TECHNOLOGIES IN NEUROSURGICAL PROCEDURES TO DRIVE MARKET
• 7.7 MICROSURGERY
  • 7.7.1 RISING INTERSECTION OF MINIMALLY INVASIVE SURGERY AND SURGICAL ROBOTS TO SUPPORT GROWTH
• 7.8 OTOLOGICAL SURGERY
  • 7.8.1 RISING PREVALENCE OF EAR-RELATED DISORDERS
• 7.9 OTHER APPLICATIONS

8 SURGICAL ROBOTS MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 HOSPITALS & CLINICS
  • 8.2.1 INCREASING ROBOTIC-ASSISTED SURGERIES TO PROPEL MARKET GROWTH
• 8.3 AMBULATORY SURGERY CENTERS
  • 8.3.1 GROWING PATIENT PREFERENCE FOR AMBULATORY CENTERS DUE TO COST-EFFECTIVE TREATMENTS TO DRIVE GROWTH

9 SURGICAL ROBOTS MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
  • 9.2.2 US
    • 9.2.2.1 US to dominate North American surgical robots market
  • 9.2.3 CANADA
    • 9.2.3.1 Increased adoption of surgical robots to drive market
• 9.3 EUROPE
  • 9.3.1 EUROPE: MACROECONOMIC OUTLOOK
  • 9.3.2 GERMANY
    • 9.3.2.1 Germany to dominate European surgical robots market
  • 9.3.3 UK
    • 9.3.3.1 Rising investments to support adoption of surgical robots to aid market
  • 9.3.4 FRANCE
    • 9.3.4.1 Favorable investments and growing demand for surgical robotic systems to boost growth
  • 9.3.5 SPAIN
    • 9.3.5.1 Increasing number of robotic-assisted surgical procedures and initiatives to fuel growth
  • 9.3.6 ITALY
    • 9.3.6.1 Increasing number of robotic surgical procedures to propel market
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
  • 9.4.2 JAPAN
    • 9.4.2.1 Japan to dominate APAC market
  • 9.4.3 CHINA
    • 9.4.3.1 Increasing initiatives from domestic players to boost market
  • 9.4.4 INDIA
    • 9.4.4.1 Developments in healthcare infrastructure in India to support market growth
  • 9.4.5 AUSTRALIA
    • 9.4.5.1 Increasing implementation and development of surgical robotic training programs in Australia to boost market
  • 9.4.6 SOUTH KOREA
    • 9.4.6.1 Increasing installation of surgical robots to ensure market growth
  • 9.4.7 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
  • 9.5.2 BRAZIL
    • 9.5.2.1 Rising incidence of target diseases and growing healthcare expenditure to drive market
  • 9.5.3 MEXICO
    • 9.5.3.1 Growing emphasis on surgical robotics to support market growth
  • 9.5.4 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
  • 9.6.2 GCC COUNTRIES
    • 9.6.2.1 Robust healthcare industry to drive market
  • 9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SURGICAL ROBOTS MARKET
• 10.3 REVENUE ANALYSIS
• 10.4 MARKET SHARE ANALYSIS
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 10.5.5.1 Company footprint
    • 10.5.5.2 Offering footprint
    • 10.5.5.3 Application footprint
    • 10.5.5.4 End-user footprint
    • 10.5.5.5 Region footprint
• 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 DYNAMIC COMPANIES
  • 10.6.3 STARTING BLOCKS
  • 10.6.4 RESPONSIVE COMPANIES
  • 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 10.7 VALUATION & FINANCIAL METRICS
  • 10.7.1 FINANCIAL METRICS
  • 10.7.2 COMPANY VALUATION
• 10.8 BRAND/PRODUCT COMPARISON
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 PRODUCT & SERVICE LAUNCHES AND APPROVALS
  • 10.9.2 DEALS
  • 10.9.3 EXPANSIONS
  • 10.9.4 OTHER DEVELOPMENTS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 INTUITIVE SURGICAL
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products & services offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Product approvals
      • 11.1.1.3.2 Deals
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Right to win
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses & competitive threats
  • 11.1.2 STRYKER
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Product launches
      • 11.1.2.3.2 Deals
      • 11.1.2.3.3 Expansions
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Right to win
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses & competitive threats
  • 11.1.3 MEDTRONIC
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Product approvals
      • 11.1.3.3.2 Deals
      • 11.1.3.3.3 Expansions
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Right to win
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses & competitive threats
  • 11.1.4 SMITH+NEPHEW
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Product & service launches and enhancements
    • 11.1.4.4 MnM view
      • 11.1.4.4.1 Right to win
      • 11.1.4.4.2 Strategic choices
      • 11.1.4.4.3 Weaknesses & competitive threats
  • 11.1.5 ZIMMER BIOMET
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products offered
    • 11.1.5.3 Recent developments
      • 11.1.5.3.1 Product approvals
      • 11.1.5.3.2 Deals
      • 11.1.5.3.3 Other developments
    • 11.1.5.4 MnM view
      • 11.1.5.4.1 Right to win
      • 11.1.5.4.2 Strategic choices
      • 11.1.5.4.3 Weaknesses & competitive threats
  • 11.1.6 ASENSUS SURGICAL INC.
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products offered
    • 11.1.6.3 Recent developments
      • 11.1.6.3.1 Product approvals
      • 11.1.6.3.2 Deals
  • 11.1.7 SIEMENS HEALTHINEERS AG
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Deals
  • 11.1.8 RENISHAW PLC
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products offered
    • 11.1.8.3 Recent developments
      • 11.1.8.3.1 Product approvals
  • 11.1.9 CMR SURGICAL
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products offered
    • 11.1.9.3 Recent developments
      • 11.1.9.3.1 Deals
  • 11.1.10 THINK SURGICAL INC.
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products offered
    • 11.1.10.3 Recent developments
      • 11.1.10.3.1 Product approvals
      • 11.1.10.3.2 Deals
  • 11.1.11 CORIN GROUP
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products offered
    • 11.1.11.3 Recent developments
      • 11.1.11.3.1 Product launches & approvals
  • 11.1.12 MICROSURE
    • 11.1.12.1 Business overview
    • 11.1.12.2 Products offered
    • 11.1.12.3 Recent developments
      • 11.1.12.3.1 Other developments
  • 11.1.13 TITAN MEDICAL INC.
    • 11.1.13.1 Business overview
    • 11.1.13.2 Products offered
    • 11.1.13.3 Recent developments
      • 11.1.13.3.1 Deals
      • 11.1.13.3.2 Other developments
  • 11.1.14 AVATERAMEDICAL GMBH (A SUBSIDIARY OF AVATERAMEDICAL N.V.)
    • 11.1.14.1 Business overview
    • 11.1.14.2 Products offered
  • 11.1.15 MEDICAL MICROINSTRUMENTS
    • 11.1.15.1 Business overview
    • 11.1.15.2 Products offered
    • 11.1.15.3 Recent developments
      • 11.1.15.3.1 Product approvals
      • 11.1.15.3.2 Deals
      • 11.1.15.3.3 Other developments
  • 11.1.16 MEDICAROID CORPORATION
    • 11.1.16.1 Business overview
    • 11.1.16.2 Products offered
    • 11.1.16.3 Recent developments
      • 11.1.16.3.1 Product approvals
      • 11.1.16.3.2 Deals
  • 11.1.17 BRAINLAB AG
    • 11.1.17.1 Business overview
    • 11.1.17.2 Products offered
    • 11.1.17.3 Recent developments
      • 11.1.17.3.1 Product approvals
      • 11.1.17.3.2 Deals
  • 11.1.18 ECENTIAL ROBOTICS
    • 11.1.18.1 Business overview
    • 11.1.18.2 Products offered
    • 11.1.18.3 Recent developments
      • 11.1.18.3.1 Product approvals
      • 11.1.18.3.2 Deals
  • 11.1.19 GLOBUS MEDICAL, INC.
    • 11.1.19.1 Business overview
    • 11.1.19.2 Products offered
  • 11.1.20 JOHNSON & JOHNSON
    • 11.1.20.1 Business overview
    • 11.1.20.2 Products offered
    • 11.1.20.3 Recent developments
      • 11.1.20.3.1 Product approvals
• 11.2 OTHER PLAYERS
  • 11.2.1 MOMENTIS INNOVATIVE SURGERY LTD.
  • 11.2.2 TINAVI MEDICAL TECHNOLOGIES CO LTD
  • 11.2.3 DISTALMOTION
  • 11.2.4 MONTERIS
  • 11.2.5 NOVUS SAGLIK URUNLERI AR-GE DANISMANLIK

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS